Andexanet Alfa for Bleeding with Factor Xa Inhibitors

被引：4
|
作者：
Tomoda, Haruo [1 ]
机构：
[1] Tokyo Heart Inst, Tokyo, Japan
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2019年 / 381卷 / 02期
关键词：
REVERSAL; ANTICOAGULATION;
D O I：
10.1056/NEJMc1906058
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [41] The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis
    Siegal, Deborah M.
    Forbes, Nauzer
    Eikelboom, John
    Beyer-Westendorf, Jan
    Cohen, Alexander T.
    Xu, Lizhen
    Connolly, Stuart J.
    Crowther, Mark
    CIRCULATION, 2024, 149 (16) : 1315 - 1318
  • [42] Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors
    Fera, Toni
    Burnett, Allison
    Grandoni, Jessica
    Moore, Mary R.
    Nussbaum, Barbara B.
    Pollack Jr, Charles V.
    Rose, Anne E.
    Spinler, Sarah A.
    Streiff, Michael B.
    Turck, Charles J.
    Fanikos, John
    JOURNAL OF PHARMACY PRACTICE, 2025, 38 (01) : 7 - 12
  • [43] Andexanet Alfa, a Universal Antidote for Reversal of Anticoagulation of Factor Xa Inhibitors in Healthy Human Volunteers.
    Crowther, Mark
    Gold, Alexander M.
    Lu Genmin
    Leeds, Janet M.
    Wiens, Brian L.
    Mathur, Vandana
    Castillo, Janice
    Conely, Pamela B.
    Connolly, Stuart J.
    Curnutte, John T.
    STROKE, 2016, 47
  • [44] Coagulation Factor Xa (Recombinant), Inactivated-zhzo (Andexanet Alfa)
    Baker, Danial E.
    HOSPITAL PHARMACY, 2018, 53 (05) : 286 - 291
  • [45] Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation
    Carpenter, Elise
    Singh, Divita
    Dietrich, Eric
    Gums, John
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2019, 10
  • [46] ANDEXANET ALFA REVERSES ANTICOAGULATION IN FACTOR XA-ASSOCIATED MAJOR BLEEDING IN ANNEXA-4 STUDY
    Connolly, Stuart
    Crowther, Mark
    Milling, Truman
    Eikelboom, John
    Gibson, C. Michael
    Demchuk, Andrew
    Yue, Patrick
    Lu, Genmin
    Conley, Pamela
    Verhamme, Peter
    Schmidt, Jeannot
    Middeldorp, Saskia
    Cohen, Alexander
    Beyer-Westendorf, Jan
    Albaladejo, Pierre
    Lopez-Sendon, Jose
    Goodman, Shelly
    Leeds, Janet
    Neuman, Richey
    Curnutte, John
    CRITICAL CARE MEDICINE, 2019, 47
  • [47] Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis
    White, C. Michael
    Caroti, Kimberly Snow
    Bessada, Youssef
    Hernandez, Adrian V.
    Baker, William L.
    Dobesh, Paul P.
    van Haalen, Heleen
    Rhodes, Kirsty
    Coleman, Craig I.
    PHARMACOTHERAPY, 2024, 44 (05): : 394 - 408
  • [48] Real world utilization of Andexanet alfa in the management of oral factor Xa inhibitor-associated gastrointestinal bleeding
    Brown, Caitlin S.
    Mattson, Alicia E.
    Cabrera, Daniel
    Coelho-Prabhu, Nayantara
    Rabinstein, Alejandro A.
    Dettling, Theresa
    McBane II, Robert D.
    Bellolio, Fernanda
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2023, 73 : 1 - 6
  • [49] Comment: Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent
    Gilbert, Brian W.
    Reeder, Jacob A.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (11) : 1167 - 1167
  • [50] Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding
    Stevens, Victoria M.
    Trujillo, Toby C.
    Kiser, Tyree H.
    MacLaren, Robert
    Reynolds, Paul M.
    Mueller, Scott W.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
12345